Opportunity
Federal Register #NHTSA-2025-0788
NHTSA Request for Public Comment on DMS Drowsiness Detection Test Procedure Research
Buyer
National Highway Traffic Safety Administration
Posted
August 26, 2026
Respond By
October 26, 2026
Identifier
NHTSA-2025-0788
The National Highway Traffic Safety Administration (NHTSA), under the Department of Transportation, is seeking public comment on a proposed information collection for research on Driver Monitoring System (DMS) drowsiness detection test procedures. - Government Buyer: - National Highway Traffic Safety Administration (NHTSA) - Office of Vehicle Safety Research - Purpose: - Collect data to develop and validate test protocols for detecting driver drowsiness using DMS technology - Research will inform manufacturers, researchers, and regulators - Study Details: - Involves 66 licensed driver participants - Locations: Phoenix, Arizona (test track) and Iowa City, Iowa (driving simulator) - Activities include participant screening, consent, study drives, data collection with cameras and DMS, and analysis - No OEMs or vendors are specified; this is not a procurement for products or services - Unique Requirements: - Focus on developing robust, validated test procedures for DMS efficacy - Data collection includes questionnaires, logs, and driving tasks under various conditions - This is a notice for public comment, not a solicitation or contract award
Description
The National Highway Traffic Safety Administration (NHTSA) is seeking public comments on a new information collection request to develop a test procedure for drowsiness detection using Driver Monitoring Systems (DMS). The study involves voluntary participation from licensed drivers in Phoenix, Arizona, and Iowa City, Iowa, to evaluate drowsiness detection methods, test drive methods, and driver characteristics. The data collection includes test track driving and driving simulator sessions, with participants undergoing various assessments and questionnaires. The goal is to develop a robust and validated test protocol for evaluating DMS efficacy to be used by manufacturers, researchers, and regulators.